北京pk10开奖视频:布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 基本信息

中文名称:
布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 
中文别名:
左布地奈德;
16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 
英文名称:
Budesonide
英文别名:
budesonide;
SPIROCORT;
S-1320;
Respules;
Micronyl;
RHINOCORT;
Entocort;
BIDIEN;
Budeson;
Budesonide,(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione;
PREFERID;
Budesonide;
PULMICORT;
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione 
CAS No.:
51333-22-3
分 子 式:
C25H34O6
分 子 量:
430.54
精确分子量:
430.23600
PSA:
93.06000
EINECS:
257-139-7
InChI:
InChI=1/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17?,18-,20?,21?,22?,23-,24-,25?/m0/s1
危险品标志:
风险术语:
R40   
安全术语:
S22;S36
分子结构式:
SDS:
查看

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 制备方法及用途

制备方法

用于治疗皮肤病、哮喘等病症

用途简介

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 物化性质

外观与性状:
白色固体
密度:
1.27 g/cm3
熔点:
221-232oC (dec.)
沸点:
599.7oC at 760mmHg
闪点:
201.8oC
折射率:
1.592
存储条件/存储方法:
库房通风低温干燥

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 安全信息

海关代码:
29372900
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R40
安全说明:
S22-S36
RTECS号:
TU3723000
危险标志:
Xn:Harmful

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TU3723000
CHEMICAL NAME :
Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta, 16-alpha)-
CAS REGISTRY NUMBER :
51333-22-3
LAST UPDATED :
199604
DATA ITEMS CITED :
19
MOLECULAR FORMULA :
C25-H34-O6
MOLECULAR WEIGHT :
430.59

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
34 ug/kg
TOXIC EFFECTS :
Skin and Appendages - dermatitis, allergic (after systemic exposure)
REFERENCE :
ANZJB8 Australian and New Zealand Journal of Medicine. (Modern Medicine of Australia Pty., Ltd., 100 Pacific Highway, North Sydney, 2060, Australia) V.1- 1971- Volume(issue)/page/year: 22,511,1992
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>3200 mg/kg
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
138 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Blood - changes in spleen
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
58400 ug/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Blood - changes in spleen
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
98900 ug/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4750 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
179 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
53600 ug/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
124 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
173 mg/kg
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from stomach Gastrointestinal - hypermotility, diarrhea Blood - changes in spleen
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4377,1985 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45500 ug/kg/13W-C
TOXIC EFFECTS :
Endocrine - other changes Blood - changes in spleen Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4389,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3640 ug/kg/26W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in bladder weight Endocrine - changes in adrenal weight Blood - pigmented or nucleated red blood cells
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 37,37,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
18200 mg/kg/13W-C
TOXIC EFFECTS :
Liver - other changes Endocrine - other changes Skin and Appendages - primary irritation (after topical exposure)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,4414,1985 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
220 ug/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,5093,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
44 ug/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,5093,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
540 ug/kg
SEX/DURATION :
female 17-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - sex ratio Reproductive - Effects on Newborn - physical
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,5093,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
21600 ng/kg
SEX/DURATION :
female 17-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,5093,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1625 ug/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 37,43,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
325 ug/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 37,43,1987

布地奈德; 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮 MSDS


Section 1. Chemical Product and Company Identification
    Budesonide        Catalog    
    YY448, YY1420, B1581,
    Common Name/
    Number(s).
    Trade Name
    51333-22-3
    CAS#
    Manufacturer
    Commercial Name(s)
    Synonym
    Budesonide

Section 4. First Aid Measures
    Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least
    Eye Contact
    15 minutes. Get medical attention.
    In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove
    Skin Contact
    contaminated clothing and shoes. Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
    attention.
    Serious Skin Contact        Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.    
    Inhalation        If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get    
    medical attention.
    Serious Inhalation        Not available.    
    Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
    Ingestion
    unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms
    appear.
    Serious Ingestion        Not available.    

Section 5. Fire and Explosion Data
    Flammability of the Product May be combustible at high temperature.
    Auto-Ignition Temperature Not available.
    Not available.
    Flash Points
    Not available.
    Flammable Limits
    These products are carbon oxides (CO, CO2).
    Products of Combustion
    Fire Hazards in Presence of Slightly flammable to flammable in presence of heat.
    Various Substances
    Risks of explosion of the product in presence of mechanical impact: Not available.
    Explosion Hazards in
    Risks of explosion of the product in presence of static discharge: Not available.
    Presence of Various
    Substances
    SMALL FIRE: Use DRY chemical powder.
    Fire Fighting Media
    LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
    and Instructions
    Not available.
    Special Remarks on
    Fire Hazards
    Not available.
    Special Remarks on
    Explosion Hazards

Section 6. Accidental Release Measures
    Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading
    Small Spill
    water on the contaminated surface and dispose of according to local and regional authority requirements.
    Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on
    Large Spill
    the contaminated surface and allow to evacuate through the sanitary system.
    Budesonide

Section 7. Handling and Storage
    Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do not
    Precautions
    ingest. Do not breathe dust. Wear suitable protective clothing. If ingested, seek medical advice immediately and
    show the container or the label. Avoid contact with skin and eyes.
    Keep container tightly closed. Keep container in a cool, well-ventilated area.
    Storage

Section 8. Exposure Controls/Personal Protection
    Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
    Engineering Controls
    recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
    airborne contaminants below the exposure limit.
    Personal Protection        Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.    
    Personal Protection in Case Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to
    avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE
    of a Large Spill
    handling this product.
    Not available.
    Exposure Limits

Section 9. Physical and Chemical Properties
    Solid.        Odorless.    
    Physical state and        O dor    
    appearance
    Not available.
    Taste
    430.59 g/mole
    Molecular Weight
    White. Off-white.
    Color
    Not applicable.
    pH (1% soln/water)
    Not available.
    Boiling Point
    226.5°C (439.7°F)
    Melting Point
    Not available.
    Critical Temperature
    Not available.
    Specific Gravity
    Not applicable.
    Vapor Pressure
    Not available.
    Vapor Density
    Not available.
    Volatility
    Not available.
    Odor Threshold
    Not available.
    Water/Oil Dist. Coeff.
    Not available.
    Ionicity (in Water)
    Not available.
    Dispersion Properties
    Insoluble in cold water.
    Solubility
    Practically insoluble in Heptane.
    Sparingly soluble in Ethanol.
    Freely soluble in Chloroform.

Section 10. Stability and Reactivity Data
    The product is stable.
    Stability
    Not available.
    Instability Temperature
    Conditions of Instability Excess heat
    Incompatibility with various Not available.
    substances
    Budesonide
    Non-corrosive in presence of glass.
    Corrosivity
    Not available.
    Special Remarks on
    Reactivity
    Not available.
    Special Remarks on
    Corrosivity
    Will not occur.
    Polymerization

Section 11. Toxicological Information
    Inhalation. Ingestion.
    Routes of Entry
    Toxicity to Animals        Acute oral toxicity (LD50): >3200 mg/kg [Rat].    
    Chronic Effects on Humans Not available.
    Hazardous in case of skin contact (irritant).
    Other Toxic Effects on
    Humans        Slightly hazardous in case of ingestion, of inhalation.    
    Not available.
    Special Remarks on
    Toxicity to Animals
    May cause adverse reproductive effects and birth defects (teratogenic)
    Special Remarks on
    Chronic Effects on Humans
    Potential Health Effects:
    Special Remarks on other
    Skin: Causes skin irritation.
    Toxic Effects on Humans
    Eyes: Causes eye irritation.
    Inhalation: May cause respiratory tract irritation.
    Ingestion: May cause nausea, vomiting, headache, increased thirst/dry mouth, swollen or moon face, swollen ankels,
    skin striae or markings, acne, respiratory infection. May also affect behavior/central nervous system (Central nervous
    system depression, confusion, excitement, restlessness, a false sense of well-being, severe mood swings, unusual
    tiredness or weakness, dizzienss, drowsiness, nervousness or difficulty sleeping), cardiovascular system (irregular
    heartbeat, chest pain, high blood pressure). May also cause pain in the hips, knees, back, ribs, arms, shoulders, legs,
    muscle cramps, numbness or tingling in fingers, toes, or other areas, eye pain, decreased or blurred vision, fever, sore
    throat, sneezing, cough, or other signs of infection, wounds that won't heal, frequent urination, unusual bruising,
    increased growth of hair on face or body, weight gain or loss
    Medical Conditions Aggravated by Exposure: Tuberculosis; hypertension; heart problems; diabetes; osteoporosis;
    glaucoma; cataracts; chronic liver disease; chicken pox or measles; Cushing's Syndrome; stomach or intestinal
    disease, inclulding colitis; allergic reaction to Budesonide; pregnancy.

Section 12. Ecological Information
    Not available.
    Ecotoxicity
    Not available.
    BOD5 and COD
    Products of Biodegradation Possibly hazardous short term degradation products are not likely. However, long term degradation products may
    arise.
    The product itself and its products of degradation are not toxic.
    Toxicity of the Products
    of Biodegradation
    Not available.
    Special Remarks on the
    Products of Biodegradation
    Budesonide

Section 13. Disposal Considerations
    Waste must be disposed of in accordance with federal, state and local environmental control
    Waste Disposal
    regulations.

Section 14. Transport Information
    Not a DOT controlled material (United States).
    DO T Cl assi fi cati on
    Not applicable.
    Identification
    Not applicable.
    Special Provisions for
    Transport
    DO T (Pi ctograms)

Section 15. Other Regulatory Information and Pictograms
    No products were found.
    Federal and State
    Regulations
    California prop. 65: This product contains the following ingredients for which the State of California has found to
    California
    cause cancer which would require a warning under the statute: No products were found.
    Proposition 65
    Warnings
    California prop. 65: This product contains the following ingredients for which the State of California has found to
    cause birth defects which would require a warning under the statute: No products were found.
    Other Regulations        EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances (EINECS no.    
    257-139-7)
    Canada: Not listed on Canadian Domestic Substance List (DSL) or Canadian Non- Domestic Substance List (NDSL).
    China: Not listed on National Inventory.
    Japan: Not listed on National Inventory (ENCS).
    Korea: Not listed on National Inventory (KECI).
    Philippines: Not listed on National Inventory (PICCS).
    Australia: Not listed on AICS.
    WHMIS (Canada) CLASS D-2A: Material causing other toxic effects (VERY TOXIC).
    Other Classifications
    Class D-2B: Material causing other toxic effects (TOXIC).
    R36/38- Irritating to eyes and skin.        S26- In case of contact with eyes, rinse    
    DSCL (EEC)
    immediately with plenty of water and seek
    medical advice.
    S37- Wear suitable gloves.
    Health Hazard
    HMIS (U.S.A.)        2 National Fire Protection    
    1 Flammability
    1 Association (U.S.A.)
    Fire Hazard
    2 0 Reactivity
    Health
    Reactivity
    0
    Specific hazard
    Personal Protection        E    
    WHMIS (Canada)
    (Pictograms)
    DSCL (Europe)
    (Pictograms)
    Budesonide
    TDG(Canada)
    (Pictograms)
    ADR (Europe)
    (Pictograms)
    Protective Equipment
    Gloves.
    Lab coat.
    Dust respirator. Be sure to use an
    approved/certified respirator or equivalent.
    Wear appropriate respirator when ventilation
    is inadequate.


SECTION 16 - ADDITIONAL INFORMATION
N/A

推荐供应商更多供应商>>

株洲森特生物科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:98% 包装信息:1/铝箔袋kg 价格:洽谈
联系方式:
联系人:南经理 电话:18873303856 手机:18873303856

中山联久生物科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:1/铝箔袋kg 价格:27,000.0元
联系方式:
联系人:汪凌宇 电话:18125352747 手机:18125352747

湖北鑫鸣泰化学有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:100kg,200kg 价格:1.0元 - 1.0元
联系方式:
联系人:黄 电话:027-50662354 手机:13264726139

湖北万得化工有限公司

产品介绍:
产品名称:左布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶,200kg镀锌铁桶/塑料桶,1t吨袋 价格:1.0元 - 1,000.0元
联系方式:
联系人:许甜 电话:15377098682 手机:15377098682

湖北广奥生物科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶,200kg镀锌铁桶/塑料桶,1t吨袋 价格:1.0元 - 1,000.0元
联系方式:
联系人:王 电话:18162699091 手机:18162699092

武汉鑫伟烨化工有限公司

产品介绍:
产品名称:左布地奈德 Cas号:51333-22-3 纯度:98% 包装信息:25kg,25kg 价格:1.0元 - 1.0元
联系方式:
联系人:郭经理 电话:027-85953558 手机:13377862267

上海源叶生物科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:HPLC≥98% 包装信息:100mg 价格:300.0元
联系方式:
联系人:Alice 电话:021-61845781 手机:13585604150

武汉润泽伟业科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:25kg,1kg 价格:1.0元 - 1.0元
联系方式:
联系人:徐海涛 电话:02750779735 手机:15172337137

湖北帝伯化工有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99 包装信息:1,1 价格:洽谈
联系方式:
联系人:雷 电话:15872383390 手机:15872383390

湖北旻祺丰达科技有限公司

产品介绍:
产品名称:布地奈德 Cas号:51333-22-3 纯度:99% 包装信息:25kg 价格:洽谈
联系方式:
联系人:刘经理 电话:13260520667 手机:13260520667
229| 845| 622| 636| 861| 495| 398| 995| 602| 496|